KLK3 and prostate carcinoma: A possible explanation for this discrepancy could be that in the ProtecT cohort, men were invited for a PSA test (i.e. PSA screening), while the cohort in this study encompassed patients referred by their general practitioner upon clinical suspicion of prostate cancer.